ARTHUR-D.-LITTLE
10.2.2020 14:55:09 CET | Business Wire | Press release
Arthur D. Little (ADL) has published its annual telecoms study, which highlights the need for greater reconfiguration in the global telecoms industry. Backed by client conversations, a global survey and interviews targeting investors, board members and senior executives of telecom operators, the study has revealed that inorganic growth options are a viable tool for operators to survive in the challenging telecoms market, with more than 90 percent of respondents agreeing. Over 60 percent of respondents also believe that the telecoms sector was facing disruption.
Technology and new business models are disintegrating and reconfiguring the typical telco delivery model, and this is leading to competition from a number of players along the telco value chain. In many situations, organic options beyond cost optimization are limited because the market is reaching maturity. At the same time, telco assets with varying risk and return profiles are becoming attractive to financial investors because telco assets can be mutualized under new ownership. If telcos do not succeed in aligning execution realities with investor expectations, shareholders are more likely to choose other options. One growing trend involves alternate investors that reconfigure or unbundle assets to extract better value.
To secure future growth, telcos will need to take advantage of mutualizing assets and creating focused platforms for growth, transformation and value creation, which is facilitated by disaggregating the telecom value chain. To do this, telcos must continue to make balanced investments between organic and inorganic options:
- Innovate the core based on local competition
- Build capabilities to prepare for the future, particularly digital transformation
- Secure reasons to be part of sustainable economics or drive in-market consolidation to reach sustainable economics
- Accelerate M&A in resulting focus areas beyond the core – i.e., B2C, as well as ICT, B2B2X and wholesale, to prepare for the future (to compensate for stagnating or declining core business).
“Telecom companies are lagging behind other industries in shareholder value creation, while wrestling to define optimal asset structures to prepare themselves for the future,” said Karim Taga, Managing Partner and Global Practice Leader TIME at Arthur D. Little . “Amid substantial competition from within and outside the industry, as well as sustained investment requirements, telcos must explore avenues for growth from both organic and inorganic perspectives in order to effectively embrace the future.”
“Embracing the future,” the newest edition of Arthur D. Little’s annual study on the telecoms industry, is based on more than 100 interviews with senior industry executives, investors and shareholders. It draws from a review of over 4,300 deals in relevant sectors and analysis of operator strategies across the globe.
To download the full report, visit: www.adlittle.com/EmbracingTheFuture .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200210005468/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IQM Secures €50M Financing to Accelerate Global Growth30.3.2026 08:00:00 CEST | Press release
€50 million financing package from funds and accounts managed by BlackRock will support IQM to scale operations, accelerate product development, and strengthen its market position. The facility will support acceleration of IQM’s technology roadmap, fuel R&D, support entry into additional markets, and advance IQM’s leadership in quantum computing as IQM prepares for public listing. IQM Finland Oy, a global leader in full-stack superconducting quantum computers (“IQM”, “IQM Quantum Computers” or the “Company”), today announced it has secured a €50 millionfinancing package from funds and accounts managed by BlackRock. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260329996942/en/ IQM Radiance quantum computer is located in IQM's showroom in Espoo, Finland. This facility will support acceleration of IQM’s technology roadmap, fuel R&D, support entry into additional markets, and advance IQM’s leadership in quantum computing. This
Bureau Veritas and Trade Technologies Join Forces to Streamline Global Trade Operations30.3.2026 07:45:00 CEST | Press release
Bureau Veritas, a global leader in Testing, Inspection, and Certification services (TIC), through its Swiss branch Government Services Division, is pleased to announce a strategic agreement with Trade Technologies, the leading provider of trade finance automation, connectivity and transaction management services. This collaboration is a significant step toward reducing the complexities of international trade operations, particularly in regions where regulatory and inspection controls remain stringent. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260329411683/en/ Addressing Critical Trade Finance Challenges The agreement comes at a pivotal time for global trade. Letters of Credit (LCs) continue to serve as essential instruments in international commerce, particularly across the Middle East and Africa, where counterparty risk, foreign exchange controls, sanctions exposure, and regulatory oversight face ongoing challenges. In
Consortium Led by Axelspace Selected for Japan’s Space Strategy Fund Project “Technology to Enhance Capability of Next Generation Earth Observation Satellites”30.3.2026 01:35:00 CEST | Press release
~ Creating Climate Solutions and New Market Opportunities through Source-Specific CO2 Emission and Uptake Monitoring via Satellite Constellation and Aircraft ~ Axelspace Corporation, Meisei Electric Co., Ltd., ANA HOLDINGS INC., and JIJ Inc. are pleased to announce that their jointly proposed technology development project has been selected for Japan Aerospace Exploration Agency (JAXA)’s Space Strategy Fund under the theme “Technology to Enhance Capability of Next Generation Earth Observation Satellites.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323044518/en/ Conceptual Diagram of the project. Under this Space Strategy Fund initiative, spectrometers will be newly developed and demonstrated in orbit. In the future, the project envisions the establishment of a satellite constellation capable of observations at different times of the day. Project Summary (Planned) Technology Development Theme: Technology to Enhance Cap
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
